Emerging Delivery Solutions

Mystic continues to invest in the development of its VersiDoser® and VRx2™ delivery platforms. We are advancing the development of “intelligence” delivery systems that will further enhance the patient experience, improve patient compliance and track adherence to prescribed use.

Our research includes expanding the technical capabilities of both platforms and new applications in otic, oral, injectable, dermal and pulmonary drug delivery for liquids, powders, reconstituted powders and recombination liquids. We are exploring the application of our technology for new markets including cosmetics, food and diagnostics.